FH缺陷型子宫平滑肌瘤126例临床病理与分子遗传分析
回顾性分析126例FH缺陷型子宫平滑肌瘤患者,15.9%(20/126)携带FH基因胚系致病或可能致病变异。年轻、既往肌瘤剔除史、无生育史、多发及多部位FH缺陷型平滑肌瘤与胚系突变相关(均P<0.001)。基于年龄≤45岁与多发性FH缺陷型平滑肌瘤的预测模型曲线下面积0.869,敏感度90.0%,特异度86.8%。
要点
- 15.9%(20/126)FH缺陷型子宫平滑肌瘤患者携带FH基因胚系突变。
- 年轻、既往肌瘤剔除史、无生育史、多发及多部位病变与胚系突变相关(均P<0.001)。
- 年龄≤45岁联合多发性FH缺陷型平滑肌瘤模型曲线下面积0.869。
核心结论
- 结合年龄、FH缺陷型平滑肌瘤多发及多部位分布可提高FH基因胚系突变高风险个体识别效率。
研究设计与样本
- 回顾性分析2023年1月至2025年11月浙江大学医学院附属妇产科医院126例FH缺陷型子宫平滑肌瘤患者。
- 诊断经FH或2SC免疫组化确认,采用高通量二代测序检测外周血或正常组织FH基因胚系突变。
主要发现
- 15.9%(20/126)患者携带致病性或可能致病性FH基因胚系突变。
- 年轻、既往肌瘤剔除史、无生育史、多发性平滑肌瘤更倾向携带胚系突变(均P<0.001)。
- 多发性FH缺陷型平滑肌瘤(≥2枚)及多部位分布者更倾向携带胚系突变(均P<0.001)。
关键数值与推荐
- 预测模型基于年龄≤45岁与多发性FH缺陷型平滑肌瘤,曲线下面积0.869,敏感度90.0%,特异度86.8%。
临床怎么用
- 对FH缺陷型子宫平滑肌瘤患者评估年龄、肌瘤数目及分布部位,识别FH基因胚系突变高危个体。
- 对年龄≤45岁且多发性FH缺陷型平滑肌瘤者考虑遗传咨询与FH基因胚系检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the clinicopathological features of fumarate hydratase (FH)-deficient uterine leiomyomas associated with germline mutations of FH gene, and to provide a basis for efficient screening of high-risk individuals with FH gene germline mutations. Methods: The clinical data of 126 patients with FH-deficient uterine leiomyoma diagnosed in Women's Hospital, Zhejiang University School of Medicine from January 2023 to November 2025 were collected and retrospectively analyzed. The diagnosis of FH-deficient uterine leiomyoma in all patients was confirmed by FH or 2-succinate-cysteine (2SC) immunohistochemistry. Peripheral blood or normal tissue samples of all patients were collected for FH gene germline mutation detection by high-throughput next-generation sequencing technology. Results: A total of 15.9% (20/126) of the patients with FH-deficient uterine leiomyoma carried pathogenic or likely pathogenic germline mutations of FH gene. Univariate analysis showed that younger age, previous myomectomy history, no history of childbearing, presence of multiple leiomyomas, especially, patients with multiple FH-deficient leiomyomas (≥2 FH-deficient leiomyomas) and multifocal FH-deficient leiomyomas (FH-deficient leiomyomas distributed in different parts of the uterus, cervix, broad ligament, etc.) were more likely to carry FH gene germline mutations (all P<0.001). The prediction model based on "age≤45 years" and "multiple FH-deficient leiomyomas" had good predictive efficacy (area under the curve was 0.869, sensitivity was 90.0%, and specificity was 86.8%). Conclusion: Integration of clinicopathological features including patient age, multiple and multifocal distribution of FH-deficient leiomyomas could effectively improve the identification of high-risk individuals for FH gene germline mutation, so as to provide a basis for the development of accurate genetic screening. 目的: 探讨延胡索酸水合酶(FH)缺陷型子宫平滑肌瘤患者与FH基因胚系突变有关的临床病理特征,为高效筛选FH基因胚系突变高危个体提供依据。 方法: 收集2023年1月至2025年11月期间浙江大学医学院附属妇产科医院诊断的126例FH缺陷型子宫平滑肌瘤患者的临床资料进行回顾性分析。所有患者FH缺陷型子宫平滑肌瘤的诊断均经FH或2-琥珀酸-半胱氨酸(2SC)免疫组化染色确认。采用高通量二代测序技术对所有患者的外周血或正常组织样本进行FH基因胚系突变检测。 结果: 15.9%(20/126)的FH缺陷型子宫平滑肌瘤患者携带致病性或可能致病性FH基因胚系突变。单因素分析显示,年轻、既往肌瘤剔除史、无生育史、存在多发性平滑肌瘤,尤其是存在多发性FH缺陷型平滑肌瘤(FH缺陷型平滑肌瘤≥2枚)以及多部位FH缺陷型平滑肌瘤(FH缺陷型平滑肌瘤分布于子宫体、子宫颈、阔韧带等不同部位)的患者更倾向于携带FH基因胚系突变(P均<0.001)。基于“年龄≤45岁”与“多发性FH缺陷型平滑肌瘤”构建的预测模型,具有良好预测效能(曲线下面积为0.869,敏感度为90.0%,特异度为86.8%)。 结论: 结合患者年龄、FH缺陷型平滑肌瘤多发及多部位分布等临床病理特征,可有效提高对FH基因胚系突变高风险人群的识别效率,从而为制定精准的遗传筛查提供依据。.
引用
- Chen LX, Liang Y, Zhang XF, et al. [Clinicopathological and molecular genetic analysis of 126 cases of fumarate hydratase-deficient uterine leiomyomas]. Zhonghua Fu Chan Ke Za Zhi. 2026. PMID: 42477919. doi:10.3760/cma.j.cn112141-20260202-00087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。